Bayer Unveils Indian Joint Venture with Zydus Cadila

Jan. 28, 2011
Bayer Zydus Pharma will focus on women's healthcare, diagnostic imaging, general medecines and oncology.

Chemical and pharmaceutical group Bayer said on Jan. 28 that it would create a joint venture in India with Zydus Cadila to enhance its presence in that country's fast growing market.

Bayer Zydus Pharma will focus on women's healthcare, diagnostic imaging, general medecines and oncology, a Bayer statement said.

"With this step, we aim to significantly accelerate our capabilities to better serve the fast growing Indian market," it quoted Joerg Reinhardt, chief executive of Bayer's HealthCare unit, as saying.

The new company is expected to have staff of 600, drawn from the parent groups, but financial details were not provided.

Copyright Agence France-Presse, 2011

Popular Sponsored Recommendations

Powering Up Productivity: The Transformative Power of AP Automation in Manufacturing

Oct. 25, 2023
Discover how AP Automation is revolutionizing the manufacturing industry, driving efficiency, cost savings, and security. In today's world, automation is the key to staying competitive...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

The Executive Guide to Best Practices for Ecommerce Integration

Oct. 2, 2023
Get ready to elevate your post-checkout experiences and thrive in today's unpredictable market. Learn why integration and automation are crucial to run operations more smoothly...

The Realist Guide to Sustainable Supply Chains

Sept. 28, 2023
A ‘roll up your sleeves’ guide to driving green line performance at your organization. Learn with this easy-to-understand ebook how to implement green supply chain management ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!